Epidemiology
-
-
Managing the severely ill dengue patients – Adult and Paediatric Intensivists
ADVA92 minutes -
Challenges in the management and diagnosis of Zika, Dengue and Chikungunya
Takeda42 minutes -
Burden of Dengue
Takeda38 minutes -
Dengue global epidemiology
Takeda4 minutes -
Economic Impact of Dengue
Takeda4 minutes -
Impact of SARS-CoV-2 interventions on dengue transmission
Takeda2 minutes -
When fever is not malaria in Latin America
Takeda2 minutes -
Dengue is the most common non-malarial febrile illness in Southern Asia and Southeastern Asia
Takeda2 minutes -
Autochthonous dengue in two Dutch visiting Département Var, Southern France (July 2020)
Takeda2 minutes
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
© Copyright 2022 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2021